Ginkgo Bioworks

The leading horizontal platform for cell programming, providing organism engineering services across pharmaceuticals, agriculture, food, materials, and industrial applications. Publicly traded on NYSE as DNA.

Location
Boston, Massachusetts, USA
Founded
2008
Investors
1
Categories
synthetic-biology, biotech, cell-programming, industrial-biotech, public

Investors

NameLocationTypeStagesPortfolio
OMX VenturesSan Francisco, California, USAbiotech-focused
seedseries-a
23